Wird geladen...
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma
Sorafenib has been the only approved systemic therapy for hepatocellular carcinoma until very recently. However, the radiologic assessment of its biological activity is a disputed matter as at least five different criteria have been proposed. In this review, we describe the characteristic of the Res...
Gespeichert in:
| Veröffentlicht in: | Hepat Oncol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096444/ https://ncbi.nlm.nih.gov/pubmed/30191059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2017-0018 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|